Abstract
In this thesis, the results of the development of two microfluidic devices (static and high-throughput) for efficient electrofucion of cells were described and evaulated. Electrofusion of cells is an important tool for generating antibody producing hybridomas. The hybridomas are the result of the fusion between a B-cell and and a myeloma cell. The conventional method for generting hybridomas has a very low efficiency (typically around 0.001%). In combination with the increasing need for antibodies, this has motivated us to explore a more efficient method for generating hybridomas. In our opinion, microfluidic chips offer several advantages compared tot the conventional systems
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Thesis sponsors | |
| Award date | 15 Nov 2013 |
| Place of Publication | Zutphen |
| Publisher | |
| Print ISBNs | 978-90-365-08254 |
| DOIs | |
| Publication status | Published - 15 Nov 2013 |
Fingerprint
Dive into the research topics of 'Electrofusion of cells on chip: from a static, parallel approach to a high-throughput, serial, microdroplet platform'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver